File Download

There are no files associated with this item.

Supplementary

Conference Paper: Preliminary efficacy of neoadjuvant nab-paclitaxel and pembrolizumab-containing regimens in early staged triple negative breast cancer (ETNBC) therapy (Oral presentation)

TitlePreliminary efficacy of neoadjuvant nab-paclitaxel and pembrolizumab-containing regimens in early staged triple negative breast cancer (ETNBC) therapy (Oral presentation)
Authors
Issue Date27-Apr-2023
Persistent Identifierhttp://hdl.handle.net/10722/340850

 

DC FieldValueLanguage
dc.contributor.authorWon, Sum Lung Jeffrey-
dc.contributor.authorLeung, Roland-
dc.contributor.authorKwok, Gerry-
dc.contributor.authorTsang, Josephine-
dc.contributor.authorLi, Bryan-
dc.contributor.authorYau, Thomas-
dc.contributor.authorYau, Tsz Kok-
dc.contributor.authorLi, Lawrence Pui Ki-
dc.contributor.authorChoi, Peter Ho Keung-
dc.contributor.authorYau, Chun Chung-
dc.contributor.authorSuen, Dacita-
dc.contributor.authorKwong, Ava-
dc.contributor.authorChiu, Joanne Wing Yan-
dc.date.accessioned2024-03-11T10:47:47Z-
dc.date.available2024-03-11T10:47:47Z-
dc.date.issued2023-04-27-
dc.identifier.urihttp://hdl.handle.net/10722/340850-
dc.languageeng-
dc.relation.ispartofGlobal Breast Cancer Conference 2023 (27/04/2023-29/04/2023, Seoul)-
dc.titlePreliminary efficacy of neoadjuvant nab-paclitaxel and pembrolizumab-containing regimens in early staged triple negative breast cancer (ETNBC) therapy (Oral presentation)-
dc.typeConference_Paper-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats